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The Brakeless protein performs many important functions during Drosophila development, but how it
controls gene expression is poorly understood. We previously showed that Brakeless can function as a
transcriptional co-repressor. In this work, we perform transcriptional proﬁling of brakeless mutant em-
bryos. Unexpectedly, the majority of affected genes are down-regulated in brakeless mutants. We de-
monstrate that genomic regions in close proximity to some of these genes are occupied by Brakeless, that
over-expression of Brakeless causes a reciprocal effect on expression of these genes, and that Brakeless
remains an activator of the genes upon fusion to an activation domain. Together, our results show that
Brakeless can both repress and activate gene expression. A yeast two-hybrid screen identiﬁed the
Mediator complex subunit Med19 as interacting with an evolutionarily conserved part of Brakeless. Both
down- and up-regulated Brakeless target genes are also affected in Med19-depleted embryos, but only
down-regulated targets are inﬂuenced in embryos depleted of both Brakeless and Med19. Our data
provide support for a Brakeless activator function that regulates transcription by interacting with Med19.
We conclude that the transcriptional co-regulator Brakeless can either activate or repress transcription
depending on context.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
Differential gene expression generates diverse cell types from
an identical DNA sequence during embryo development. Gene
expression is controlled at multiple levels, but regulation of tran-
scription is a common control step. Critical for transcription are
sequence-speciﬁc transcription factors that bind to cis-regulatory
DNA and interact with the cell's transcriptional machinery, re-
sulting in gene repression or activation. Such interactions are
mediated by co-regulators, i.e. transcriptional co-repressors or co-
activators that bridge transcription factors with the basal tran-
scription apparatus (reviewed in Mannervik et al. (1999)).
The Drosophila melanogaster Brakeless protein has previously
been shown to function as a transcriptional co-repressor (Haecker
et al., 2007). It was identiﬁed in a genetic screen for regulators of
Drosophila embryo patterning, and was shown to function as a co-
repressor for the transcription factor Tailless. Brakeless can as-
sociate with another co-repressor, Atrophin, and both Brakeless
and Atrophin are required for Tailless repressor function (Haeckernervik).
m, Sweden.et al., 2007; Wang et al., 2006). In brakeless or atrophin mutant
embryos, expression of the Tailless-regulated segmentation genes
Krüppel and knirps (kni) expand to more cells than normal.
Genetic evidence is mostly consistent with Brakeless func-
tioning as a co-repressor. Brakeless was initially identiﬁed as re-
quired for correct termination of photoreceptor axon projections
in the optic lobe of the Drosophila brain (Rao et al., 2000; Senti
et al., 2000), where it represses Runt expression in photoreceptor
R2 and R5 neurons (Kaminker et al., 2002). In parallel, it was
isolated as scribbler, since when mutated it causes a larval turning
behavior phenotype in the absence of food (Yang et al., 2000). The
gene has also been named master of thickveins (mtv), since it re-
presses expression of the Dpp receptor Thickveins in wing ima-
ginal disks (Funakoshi et al., 2001).
The brakeless locus encodes two proteins, Brakeless-A and
Brakeless-B, generated by alternative splicing. The only sequence
similarity to known functional domains is a single C2H2 zinc ﬁn-
ger located in the unique region of Brakeless-B. One additional
domain (D2) is highly conserved and present also in sequences
from other metazoa. In vertebrates, two Brakeless homologs are
present, ZNF608 and ZNF609. ZNF608 controls Rag1 and 2 ex-
pression during mouse thymocyte development, and has been
associated with body mass index in humans (Speliotes et al., 2010;
Zhang et al., 2006). ZNF609 is part of a protein network for
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Dax1 complex (van den Berg et al., 2010). Although Brakeless has
been suggested to participate in mediating SUMO-dependent
transcriptional repression (Stielow et al., 2008), the mechanisms
by which Brakeless controls transcription are not understood.
Identiﬁcation of proteins that interact with Brakeless could pro-
vide insight into such mechanisms.
The Mediator complex is a multi-subunit co-regulator of RNA
polymerase II transcription and is a key link for transducing reg-
ulatory signals from enhancer to promoter (reviewed in Kornberg
(2005)). It is evolutionarily conserved from yeast to man and
contains approximately 25 subunits. Electron microscopy has re-
vealed a four domain structure: head, middle, tail and kinase do-
mains (Tsai et al., 2014). The Med19 subunit forms a hook at the
end of the middle domain (Tsai et al., 2014), and in the absence of
the Med19 subunit, the middle module can be released and a
stable complex consisting of only head and tail isolated under
stringent conditions (Baidoobonso et al., 2007; Tsai et al., 2014).
However, puriﬁcation of Mediator from a Med19 mutant yeast
strain under more physiological conditions results in an intact
Mediator complex, but that interacts less efﬁciently with Pol II
than wild-type Mediator (Baidoobonso et al., 2007; Tsai et al.,
2014). Med19 has been implicated both in repression and in acti-
vation of transcription. In the yeast Saccharomyces cerevisiae,
Med19 is encoded by Rox3, and was ﬁrst identiﬁed as a negative
regulator of the CYC7 gene (Rosenblum-Vos et al., 1991). It is also
known as SSN7, since it suppresses the requirement of the Snf1
kinase for expression of glucose-repressed genes (Song et al.,
1996). Med19 has also been shown to negatively regulate spor-
ulation-speciﬁc genes and a Swi4p-dependent reporter (Friesen
et al., 1998; Tabtiang and Herskowitz, 1998). On the other hand, it
is also necessary for full galactose induction of GAL1 expression,
Ino2-dependent transcriptional activation, as well as for heat-
shock induced gene expression (Brown et al., 1995; Dettmann
et al., 2010; Kremer et al., 2012), and when tethered to DNA it
activates transcription (Song et al., 1996). In human cells, MED19 is
also known as LCMR1 (Lung Cancer Metastasis Related Protein 1),
and is overexpressed in a variety of cancers and cancer cell lines
(Chen et al., 2011; Ding et al., 2012; Ji-Fu et al., 2012; Li et al., 2011;
Liu et al., 2012; Sun et al., 2011; Wen et al., 2012; Zhang et al.,
2012). It is recruited by the RE1 silencing transcription factor
(REST) together with MED26, and mediates repression of neuronal
gene expression (Ding et al., 2009). Med19 is also necessary for
androgen receptor transcriptional activity in Drosophila S2 and
human prostate cancer cells (Imberg-Kazdan et al., 2013), and for
gene activation by Hox transcription factors in Drosophila imaginal
disks (Boube et al., 2014).
Here, we perform transcriptional proﬁling of brakeless mutant
embryos and identify directly regulated target genes. Un-
expectedly, we ﬁnd that most genes are down-regulated in
brakeless embryos, indicating that Brakeless can function both as a
co-repressor and as a co-activator. From a yeast two-hybrid screen,
we identify Med19 as interacting with the highly conserved
Brakeless D2 domain. Interestingly, down-regulated but not up-
regulated Brakeless target genes are also affected in embryos de-
pleted of Med19 and Brakeless. Together, these data provide sup-
port for a Brakeless co-activator function that regulates tran-
scription through Med19 in Drosophila.2. Materials and methods
2.1. Fly stocks, Brakeless and Med19 knock-down, and generation of
germline clones
D. melanogaster strains were kept at 25 °C. w1118, w; FRT2RG13 cpx sp, or offspring from female w; α-Tubulin67C-Gal4-VP16/þ
crossed to w1118 males were used as controls. UAS strains con-
taining a long hairpin targeting Brakeless (y v; P{TRiP.JF02375}attP2
derived from hairpin TR02171P.1 in the VALIUM10 vector) or a
short hairpin microRNA targeting Med19 (y sc v; P{TRiP.HMS00588}
attP2 derived from hairpin SH00843 in the VALIUM20 vector)
were kindly provided by Norbert Perrimon. Embryos where the
maternal Brakeless and/or Med19 contribution has been knocked-
down were obtained from w; α-Tubulin67C-Gal4-VP16/þ; P{TRiP}/
þ females crossed with males of the same genotype. Over-ex-
pression of maternal Brakeless in early embryos was achieved by
crossing w; α-Tubulin67C-Gal4-VP16/þ; UASp-BksB/þ or w; α-Tu-
bulin67C-Gal4-VP16/þ; UASp-BksB-VP16/þ females with males of
the same genotype.
For brakeless germline clones, FRT2RG13 ovoD1/T(1;2)OR64/CyO
(Bloomington stock #4344) was used instead of FRT2RG13 ovoD1/Dp
(?;2)bwD, S1wgSp-1Ms(2)M1bwD/CyO (stock #2125) for the FLP-FRT
dominant female sterile technique previously described (Chou and
Perrimon, 1996). The bks278 allele was used, which has a 345 bp
deletion that causes a frame shift at aa 741 resulting in addition of
79 novel amino acids (Haecker et al., 2007). It was outcrossed with
a w1118 strain to remove potential second-site mutations. FRT2RG13
bks278/CyO females were crossed with males of the genotype hs-
FLP/Y; FRT2RG13 ovoD1/CyO, and offspring larvae heat-shocked for
3 h at 37 °C on days 3, 4 and 5 after egg-laying to induce expres-
sion of the FLP recombinase. Cyþ females were crossed to
FRT2RG13 bks278/CyO males and embryos were collected, dechor-
ionated using bleach, and directly frozen in Trizol at 80 °C for
RNA isolation.
2.2. Generation of transgenes
The BksB cDNA was cloned into the pUASp vector using XbaI.
For fusion with the VP16 activation domain, an AscI site was in-
troduced in place of the stop codon by PCR. The PCR product and
BksB cDNA were digested with RsrII (cuts in Bks) and AscI (cuts in
modiﬁed pBS vector), and used to replace the 3′ end of the BksB
cDNA. The VP16 sequence was PCR ampliﬁed from pSlax-VP16 (a
gift from Johan Ericson, Karolinska Institutet) with a 5′ primer
containing an AscI site, and a 3′ primer containing XbaI and AscI
sites. The PCR product was digested with AscI and ligated into the
modiﬁed pBS-Bks plasmid. XbaI was then used to lift out the BksB-
VP16 fusion from pBS and cloned into the XbaI site of pUASp. The
constructs were injected into w1118 ﬂies following standard pro-
cedures (Rubin and Spradling, 1982).
2.3. Microarray
The microarray data, statistical and gene ontology analyses are
described in Crona et al. (2015).
2.4. Quantitative RT-PCR
Total RNAwas extracted from embryos using Trizol (Invitrogen)
according to the manufacturer's protocol. For one biological re-
plicate 20 μl embryos were collected. A total of 1 μg from each
RNA sample was subjected to DNase digestion (Sigma) and cDNA
synthesis (Applied Biosystems) according to the manufacturer's
protocol. Samples were conﬁrmed for quality and quantity using
agarose gel electorphoresis and Nanodrop. Out of 200 μl (10
diluted) total cDNA, 2 μl was subsequently used for qRT-PCR in a
total volume of 20 μl using CFX96 (BioRad instruments, Sweden)
with EvaGreen supermix (Solis BioDyne). Resulting Ct-values were
converted into raw quantities with the ΔCt method using Genorm
(Vandesompele et al., 2002), which were used to calculate the
geometric mean of two reference genes β-tubulin and RpL32 or
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sample. The stability measure M (Vandesompele et al., 2002), for
the mean of the reference genes was below 1.5 for all the condi-
tions tested. Relative expression levels were calculated by dividing
the raw quantities of the genes of interest for each sample by the
corresponding normalization factors.
2.5. Antibodies
GST-Bks (834-1151) (Haecker et al., 2007) and GST-Bks (450-
620) were produced and puriﬁed from Escherichia coli BL21 cells,
and used to immunize guinea-pigs and rats. Guinea-pig GST-Bks
(450-620) serum was used in this study.
2.6. Immunoprecipitation, Western blot and RNAi
Embryos 2–4 h old were crushed in 10 times the volume of
RIPA buffer, and then shaken vigorously at 4 °C for 20 min. Extracts
were centrifuged at 13,000 rpm for 5 min. The supernatant was
pre-cleared with protein A and G Dynabeads mix (Invitrogen)
blocked with BSA. BSA blocked protein A and G Dynabeads pre-
incubated with anti-Bks serum was mixed with 500 μl pre-cleared
extract. Protein extract and beads were rotated at 4 °C over-night,
and then washed twice with RIPA buffer, once with TEN (10 mM
Tris pH 8.0, 1 mM EDTA, 100 mM NaCl), and once with 50 mM Tris
pH 6.8. Beads were resuspended in 10% the original volume of
RIPA buffer and 1/4 volume of 5 Laemmli loading buffer and ran
on an 7.5% polyacrylamide-SDS gel together with input super-
natant mixed with 1/4 volume of 5 Laemmli loading buffer.
S2 cells, or S2 cells stably transfected with HA-tagged BksB
under a metallothionein promoter induced for 5 h with 1 mM
CuSO4, were collected at 1400 g and resuspended in RIPA buffer at
2*107 cells/ml. Lysis was carried out by vigorous shaking for
10 min at 4 °C. Lysate was centrifuged at 10,000 rpm 5 min at 4 °C,
and the supernatant recovered. Immunoprecipitation used 0.3 ml
protein extract and was performed as described for the embryo
extract. For double-stranded RNA treatment, S2 cells were split the
day before treatment. Cells were collected and washed twice in S2
cell medium without fetal calf serum (FCS). For each treatment
2*106 cells were resuspended in 0.75 ml FCS-free medium and
added to one well of a 6-well plate. 37 nM dsRNAwas added to the
cells and mixed by shaking the plate. Cells were incubated for 1 h
at 25 °C, and then 1.5 ml S2 cell medium with 15%FCS was added.
Cells were maintained at 25 °C for four days before harvesting.
Proteins were transferred to a PVDF membrane and blocked in
1% milk powder in PBST. Guinea-pig GST-Bks (450-620) serumwas
used at a 1:400 dilution, a rabbit anti-alpha-Tubulin (ab18251,
Abcam) at 1:1000, and rabbit anti-HA (ab9110, Abcam) at 1:2500.
The membrane was incubated with primary antibody for 1 h at
room temperature or overnight in a cold room. HRP-coupled rabbit
anti-guinea-pig or goat anti-rabbit (1:10,000) secondary antibody
(Dako) in 1% milk/PBST was incubated with membrane for 1 h at
room temperature. Enhanced chemiluminescence (ECL) was used
for signal detection (GE Healthcare), and the membrane exposed
to a Luminescent Image Analyzer (LAS-100plus, Fujiﬁlm). We used
MultiGauge (Fujiﬁlm) for quantiﬁcation of intensities and nor-
malized against Tubulin in the input.
2.7. Chromatin immunoprecipitation
Chromatin immunoprecipitation was carried out as described
(Holmqvist et al., 2012) from three independent chromatin ex-
tracts. In brief, two to four hour old dechorionated embryos were
dounce homogenized and cross-linked in 1.8% formaldehyde for
15 min at room temperature. Washed, cross-linked nuclei were
sonicated on a Bioruptor (Diagenode). For immunoprecipitation, amix of Protein A and G Dynabeads (Invitrogen) blocked with BSA
were either used directly as a mock control, or pre-incubated with
guineapig anti-Bks 450-620 antibody. Beads were resuspended in
chromatin extract corresponding to 40 ml of embryos followed by
incubation at 4 °C over night. After washing of beads, the cross-
links were reversed at 68 °C for at least 4 h, Proteinase K treated,
and DNA puriﬁed by phenol–chloroform extraction and ethanol
precipitation. The DNA was resuspended in 100 ml 0.1TE. Two
microliters of the ChIP material was analyzed by qPCR (EvaGreen,
Solis BioDyne) in duplicate using a CFX96 system (BioRad Instru-
ments, Sweden).
2.8. Yeast-two-hybrid and GST-pulldown
A Drosophila embryo 012þ12–24 h old cDNA library was
screened with a LexA-Bks (834-1151) bait at Hybrigenics, Paris,
France. Eleven high conﬁdence interactions were obtained from
78.5 million analyzed. One of these corresponds to Med19. Two
independent Med19 clones were isolated. The interaction was
conﬁrmed by a GST-pulldown assay, where GST-Bks (834-1151)
was incubated with in vitro translated Med 19. GST and GST-Bks
(834-1151) were expressed in E. coli BL21 and puriﬁed on glu-
tathione sepharose beads. 35S-labeled Med19 was in vitro trans-
lated with the TnT coupled reticulocyte lysate system (Promega),
and precleared with GSH-sepharose. It was then incubated with
GST-fusion proteins on GSH sepharose in NETN buffer (20 mM Tris
pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5% NP-40) for 1 h. Sepharose
beads were collected by a brief centrifugation at 2000 rpm and
washed 4 times in NETN before elution by boiling in loading
buffer. Proteins were separated on a 10% polyacrylamide-SDS gel
and exposed to a phosphoimager (FLA-3000, Fujiﬁlm).
2.9. Accession number
The microarray data complies with MIAME guidelines and is
deposited in GEO under accession number GSE60048.3. Results
3.1. Identiﬁcation of Brakeless-regulated genes
Our previous work showed that Brakeless is a co-repressor
required for Tailless function in early Drosophila embryos (Haecker
et al., 2007). To identify additional target genes in the early em-
bryo, RNA was isolated from 2–4 h old embryos derived from
brakeless (bks278) germline clones, lacking maternal Brakeless
function. As a control, germline clones were created with the
unmutagenized FRT chromosome on which the bks278 allele was
generated (Luschnig et al., 2004). The RNA was converted to cDNA
and hybridized to an Affymetrix array. After applying a cutoff at
1.5 fold change in expression level, 66 up-regulated and 174 down-
regulated genes were identiﬁed (Table 1 in Crona et al. (2015)).
Since Brakeless was previously shown to be a co-repressor, we
were surprised to ﬁnd more down-regulated than up-regulated
genes.
The genes were subjected to functional annotation analysis
using DAVID (Dennis et al., 2003), which groups genes into clus-
ters based on co-association with gene ontology (GO) terms.
Among the top clusters for the up-regulated list of genes were
terms associated with DNA binding, metal binding, RNA proces-
sing, transcription, transcription regulator activity, and pyrimidine
metabolism (Crona et al., 2015). This indicates that Brakeless re-
presses genes encoding transcription factors and other regulators
of gene expression. The top clusters for the down-regulated list of
genes include pigmentation, endopeptidase activity, synaptic
Fig. 1. Characterization of a Brakeless serum. (A) Extracts from Drosophila S2 cells
or S2 cells expressing an HA-tagged Brakeless B isoform were immunoprecipitated
with a guinea-pig anti-Brakeless (450-620) serum or control IgG, transferred to
membrane and probed with the same Brakeless serum (Bks), re-probed with Tu-
bulin as a loading control, and anti-HA antibody. Two BksB and one BksA isoforms
were detected, and only tagged BksB was recognized by the HA antibody. The
expected molecular weight of BksB is 230 kDa and BksA 90 kDa. (B) S2 cells were
treated with GFP (control) or Brakeless double-stranded RNA (Bksi), im-
munoprecipitated with Brakeless serum, blotted and probed with the Brakeless
serum and Tubulin as a control for the amount of starting material. The BksB bands
were reduced to 45% of control, and BksA reduced to 32%. (C) Chromatin im-
munoprecipitation using the Brakeless serum and control IgG from S2 cells treated
with GFP or Brakeless double-stranded RNA (Bksi). Percent input values are plotted
for an intergenic negative control locus (IG2c), and three putative target genes, pxb,
Ctr1A, and sro. Error bars indicate S.D. (n¼3 biological replicates).
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activity, immune response and aminoglycan metabolic processes
(Crona et al., 2015). This shows that many of the genes that are
activated by Brakeless are involved in metabolic and physiological
processes, and demonstrates that repressed and activated genes
fall into distinct categories.
Since Brakeless is a maternal protein, and around 80% of all
Drosophila genes are maternally contributed, Brakeless could be
regulating the identiﬁed genes either during oogenesis or zygoti-
cally in the embryo. We therefore compared our gene list to an
RNA-seq dataset that distinguishes maternal from zygotic tran-
scripts in Drosophila embryos using polymorphisms (Lott et al.,
2011). The Brakeless-regulated genes were categorized as being
maternally, zygotically, or maternally and zygotically (matzyg)
derived. The comparison revealed 34 maternal, 14 matzyg, and
3 strictly zygotic transcripts among the up-regulated genes
(Table 1 in Crona et al. (2015)). Of the down-regulated genes, 62
were maternal, 15 matzyg, and 38 zygotic. The rest were genes
without polymorphisms in the datasets, and could therefore not
be classiﬁed. Since only zygotic transcripts are going to be direct
Brakeless targets in the early embryo, we focused our analysis on
genes with matzyg or zygotic RNAs. Of note, there are more down-
regulated than up-regulated genes with early zygotic
transcription.
3.2. Brakeless occupies both up- and down-regulated genes
The relatively large number of down-regulated zygotic genes
raised the possibility that some of these are directly regulated by
Brakeless. We raised antibodies against two Brakeless parts in both
guinea-pig and rat. None of them could reliably detect Brakeless
protein in total cell or embryo extracts. However, the guinea-pig
serum raised against Brakeless amino-acids 450-620 recognized
two large and one small protein isoform in a Western blot fol-
lowing immunoprecipitation (IP) using the same serum (Fig. 1A).
Expression of HA-tagged BksB resulted in a stronger Brakeless
signal, and the protein was recognized by HA antibody after
Brakeless IP (Fig. 1A). Treating S2 cells with brakeless double-
stranded RNA reduced the Brakeless signal after IP (Fig. 1B). We
used this serum in chromatin immunoprecipitation (ChIP) from S2
cells, and detected higher occupancy at three putative target genes
compared to an intergenic control locus and compared to an IgG
control (Fig. 1C). In brakeless RNAi-treated cells, the signal was
reduced, although not statistically signiﬁcant (Fig. 1C). Taken to-
gether, these data show that the serum is able to IP and ChIP
Brakeless. We then generated Brakeless ChIP-seq data from S2
cells (manuscript in prep.). We further compared the Brakeless-
regulated genes in embryos with the Brakeless peaks in S2 cells to
search for potential direct targets, and designed quantitative PCR
(qPCR) primers for a subset of genes to be tested in ChIP from early
embryos (Table S1, location of primers in relation to S2 peaks are
shown in Fig. S1). As a positive control, we used primers from the
knirps (kni) enhancer to which Brakeless is recruited by Tailless
(Haecker et al., 2007). We performed ChIP from three biological
replicates of 2–4 h old embryos and examined occupancy of
Brakeless at both up-regulated and down-regulated genes. We
plotted occupancy as fold enrichment over a negative control locus
(background), an intergenic region devoid of any known factor. As
a control, we performed ChIP with no antibody. As expected, we
observed Brakeless occupancy at the kni enhancer (Fig. 2). Brake-
less also showed statistically signiﬁcant occupancy relative back-
ground at regions close to Copper transporter 1A (Ctr1A) and plexus
(px) (up-regulated), as well as shroud (sro), Suppressor of cytokine
signaling at 36E (Socs36E), CG30428, and highwire (hiw) among the
down-regulated genes (Fig. 2). For some genes, we did not detect
signiﬁcant Brakeless enrichment (pxb, Dad and shn in Fig. 2). Thesegenes could either be occupied by Brakeless at other, tissue-spe-
ciﬁc regulatory regions, or they could be indirect target genes.
Taken together, our ChIP and microarray data indicate that
Brakeless may directly control expression of both some up- and
some down-regulated genes.
3.3. Brakeless target genes respond to Brakeless over-expression
We thereafter focused our study on 7 genes directly regulated
by Brakeless. These are zygotically or matzyg expressed, show a
statistically signiﬁcant change in the expression array, and have
occupancy of Brakeless at the locus. The exceptions are kni, which
was not identiﬁed in the array, and hiw that was classiﬁed as
maternal. However, recent GRO-seq experiments showed that very
few genes are strictly maternal and that zygotic hiw transcripts
could be detected with this sensitive method (Saunders et al.,
2013). To validate the microarray results, we used an alternative
approach to reduce the maternal Brakeless load from early em-
bryos. We used a knockdown method that is effective in the fe-
male germline (Ni et al., 2011). Flies were generated that contain
the Gal4-VP16 activator expressed in the female germline under
control of the α-Tubulin67C promoter (α-Tubulin67C-Gal4-VP16), as
well as a UAS-hairpin construct producing Brakeless double-
stranded RNA, and embryos collected. We prepared RNA from 2–
4 h old brakeless knockdown embryos (tub4bks RNAi) and from
Fig. 2. Identiﬁcation of direct Brakeless targets. Determination of Brakeless occupancy at Brakeless-regulated genes by Chromatin immunoprecipitation-quantitative PCR in
2–4 h old w1118 embryos. Brakeless serum (anti Bks) and no antibody control ChIP signals were calculated at up- and down-regulated genes, and the values were normalized
against an intergenic locus devoid of known factors (IG2c). As a positive control the knirps enhancer (kni) was used. Error bars indicate S.D. (n¼2 and 3 biological replicates)
and * indicates Po0.05, one-tailed unpaired Student's t-test.
Fig. 3. Brakeless is a repressor of some genes. Expression of the Brakeless-target kni,
and two genes (Ctr1A, px) showing statistically signiﬁcant up-regulation (41.5 fold,
Po0.05) in a bks expression array. (A and B) Quantitative RT-PCR of Brakeless target
gene expression in 2–4 h embryos. (A) Brakeless knock-down leads to stronger ex-
pression of up-regulated targets. Columns depict average expression levels relative to a
mean of two reference genes in Brakeless knock-down embryos derived from females
expressing a long hairpin targeting Brakeless in the germline under control of an α-
tubulin Gal4-VP16 driver (tub4bks RNAi). Embryos from females with only the Gal4
driver (tub) were used as controls. S.D. (n¼3–4) relative to a mean of two reference
genes (β-tubulin and RpL32). Values from the control (tub) were set to 1. (B) Brakeless
over-expression leads to gene repression, whereas a Brakeless-VP16 fusion protein fails
to repress expression of these target genes. Embryos were derived from females ex-
pressing BksB (tub4BksB) or BksB-VP16 (tub4BksB-VP16) in the germline under
control of the α-tubulin Gal4-VP16 driver. Embryos from females with only the Gal4
driver (tub) were used as controls. Columns depict average expression levels with S.D.
(n¼3–6) relative to a mean of two reference genes (GAPDH and RpL32). Values in the
control (tub) were set to 1. * indicates Po0.05, two-tailed unpaired Student's t-test.
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males as a control (tub), and performed quantitative RT-PCR (RT-
qPCR). Up-regulation of px was observed upon Brakeless knock-
down, whereas kni up-regulation did not reach statistical sig-
niﬁcance, and Ctr1A showed no difference to control embryos in
the RT-qPCR (Fig. 3A). However, upon Brakeless over-expression,
all three genes were down-regulated (Fig. 3B). In these experi-
ments, the α-Tubulin67C-Gal4-VP16 activator was crossed to a
UASp-BksB transgene and embryos collected from w; α-Tubu-
lin67C-Gal4-VP16/þ; UASp-BksB/þ females (tub4BksB). Fig. 3B
shows that an increased maternal contribution of Brakeless leads
to down-regulation of target genes that are up-regulated in
brakeless mutant embryos.
Next, we analyzed down-regulated genes. Expression of sro and
hiwwas reduced upon Brakeless knockdown, whereas Socs36E and
CG30428 were unaffected (Fig. 4A). In embryos derived from fe-
males over-expressing Brakeless in the germline (tub4BksB), sro
and CG30428 showed a statistically signiﬁcant up-regulation,
whereas Socs36E and hiw were only marginally affected (Fig. 4B).
Taken together, these data demonstrate that Brakeless can func-
tion as an activator of direct target genes, since loss of Brakeless
reduces transcription and over-expression of Brakeless results in
increased transcription.
3.4. Brakeless activator function is maintained by fusion to an acti-
vation domain
To test if the function of Brakeless could be modulated, we
fused the VP16 activation domain to the C-terminus of the
Brakeless-B isoform. We provided early embryos with this fusion
protein by expressing it in the female germline. As can be seen in
Fig. 3B, over-expression of unmodiﬁed BksB causes repression of
kni, Ctr1A, and px whereas more variation in expression of these
genes was observed upon expression of the BksB-VP16 fusion
protein. However, sro, Socs36E, CG30428, and hiw expression was
up-regulated by the BksB-VP16 fusion protein compared to control
(Fig. 4B). This indicates that the activation function of Brakeless is
intact in the BksB-VP16 fusion protein and that activation of these
genes is not due to repression of upstream regulators. It also
provides further evidence that Brakeless directly regulates ex-
pression of these genes.3.5. Brakeless interacts with the Mediator subunit Med19
The mechanisms by which Brakeless represses and activates
transcription are not understood. Identiﬁcation of proteins that
Fig. 4. Brakeless can activate gene expression. Expression of four genes (sro,
Socs36E, CG30428, hiw) showing a statistically signiﬁcant down-regulation (41.5
fold, Po0.05) in the bks expression array. (A and B) Quantitative RT-PCR of
Brakeless target gene expression in 2–4 h embryos. (A) Down-regulation of direct
target genes in Brakeless knock-down embryos. Columns are depicted as in Fig. 2.
(B) Activation of target genes upon Brakeless or Brakeless-VP16 overexpression.
Embryos were derived from females expressing BksB (tub4BksB) or BksB-VP16
(tub4BksB-VP16) in the germline under control of the α-tubulin Gal4-VP16 driver.
Expression levels are depicted as in Fig. 2.
F. Crona et al. / Developmental Biology 407 (2015) 173–181178interact with Brakeless may provide insight into such mechanisms.
We therefore performed a yeast-two hybrid screen with the most
conserved part of Brakeless as a bait, the D2 domain, and also
included the conserved zinc-ﬁnger that is present in BksB but
absent from BksA (Fig. 5A). We screened a Drosophila embryo
cDNA library, and identiﬁed 11 genes from 78.5 million tested
interactions. One of the positives corresponds to the Mediator
subunit Med19. Two independent Med19 cDNA clones were ob-
tained, and the common part in these cDNAs, amino acids 66-202,
is the selected interaction domain that binds to Brakeless (Fig. 5A).
To conﬁrm this interaction, we used the GST-pulldown assay. GST
and GST-Bks (834-1151) were puriﬁed from E. coli and incubated
with full-length Med19 cDNA in vitro translated in the presence of
35S-Methionine. The GST-Bks fusion protein could interact with
Med19, whereas the GST control did not (Fig. 5B).
We next wanted to investigate if the Brakeless-Med19 inter-
action observed in vitro had relevance for Brakeless function
in vivo. We generated a Med19 null mutant by imprecise excision
of a P-element transposon, and recombined this allele to an FRT
chromosome in order to allow elimination of the maternal Med19
contribution to early embryos. However, females with germline
clones of the Med19 null allele failed to produce any eggs, in-
dicating that Med19 is required for oogenesis. We therefore turned
to the knockdown approach (Ni et al., 2011), using a short hairpin
microRNA targeting Med19. Since α-Tubulin67C-Gal4-VP16 does
not drive expression during early oogenesis in the germarium
(Staller et al., 2013), we were able to knock-down maternal Med19
without blocking oogenesis. Embryos derived from w; α-Tubu-
lin67C-Gal4-VP16/þ; UAS-Med19 RNAi/þ females (tub4Med19
RNAi), from w; α-Tubulin67C-Gal4-VP16/þ; UAS-bks RNAi/UAS-
Med19 RNAi females (tub4bks RNAi, Med19 RNAi), or from w; α-
Tubulin67C-Gal4-VP16/þ control females were collected. As shown
in Fig. 5C, Med19 expression is reduced in both Brakeless and
Med19 knockdown embryos, as well as Brakeless Med19 double
knockdown embryos. Surprisingly, higher bks RNA levels were
observed in Brakeless knock-down embryos (Fig. 5C). Despite the
increased bks RNA levels, decreased Brakeless protein levels weredetected in Brakeless knock-down embryos (Fig. 5D). This suggests
that Brakeless auto-regulates its own expression. Consistent with
this notion, Brakeless protein occupancy was observed at the
brakeless locus (Fig. 5E).
Brakeless target genes were then assayed by RT-qPCR. Both up-
and down-regulated genes respond to Med19 knock-down in a
manner almost identical to Brakeless knock-down (compare
Fig. 5F and G with Figs. 3A and 4A). Interestingly, in embryos
where both Med19 and Brakeless were knocked down, there was
no further up-regulation of target genes repressed by Brakeless,
but instead a return to wild-type expression levels (Fig. 5F). By
contrast, most Brakeless activated genes that were down-regu-
lated by Med19 knock-down were reduced in their expression
even further in the double knock-down (Fig. 5G). Although auto-
regulation and cross-regulation between Brakeless and Med19
complicates the interpretation of these results (Fig. 5C), they in-
dicate that the interaction between Brakeless and Med19 may be
more important for Brakeless' ability to activate transcription than
for Brakeless-mediated repression (Fig. 6).4. Discussion
The Brakeless protein has many important functions during
Drosophila development (Funakoshi et al., 2001; Haecker et al.,
2007; Rao et al., 2000; Senti et al., 2000; Yang et al., 2000), but
how this protein controls gene expression is not understood.
Previous work from our laboratory has shown that Brakeless can
function as a transcriptional co-repressor (Haecker et al., 2007).
We now demonstrate that Brakeless can both repress and activate
transcription, and that an interaction with the Mediator subunit
Med19 may be important for gene activation.
We found that embryos devoid of maternal Brakeless mis-
regulate expression of 240 genes. Although potential second-site
mutations on the brakeless mutant chromosome may affect gene
expression, several targets were conﬁrmed by brakeless RNAi ex-
periments, indicating that many of the genes are affected by lack
of Brakeless. Surprisingly, the majority of mis-regulated genes
were down-regulated in mutant embryos. A large fraction of these
genes are maternally contributed, and may therefore be regulated
by Brakeless during oogenesis. Since we wanted to identify targets
for Brakeless in the embryo, we focused on genes with early zy-
gotic transcription. Also among this class, the majority of Brake-
less-regulated genes were down-regulated in mutant embryos
(Crona et al., 2015). That some of these genes are direct Brakeless
targets is supported by several observations. First, we could detect
occupancy of the Brakeless protein at genomic regions in close
proximity to the affected genes (Fig. 2). Secondly, over-expression
of Brakeless caused a reciprocal effect on expression of these
genes, demonstrating that Brakeless levels inﬂuence their ex-
pression (Fig. 4). Thirdly, Brakeless fused to the VP16 activation
domain behaves as the unmodiﬁed Brakeless in that it up-reg-
ulates expression of these target genes (Fig. 4). These results argue
against a model where Brakeless-mediated repression indirectly
leads to gene activation, for example by controlling expression of
non-coding RNAs (van Werven et al., 2012). Taken together, our
data suggest that Brakeless can behave either as a repressor or as
an activator depending on context.
Transcriptional co-regulators are believed to mediate the re-
pressive or activating functions of DNA-binding transcription fac-
tors and therefore serve as dedicated co-repressors or co-activa-
tors, but recent experiments demonstrate that co-regulators may
switch transcriptional activity (reviewed in Mannervik (2014)). In
the case of the CtBP co-repressor, the oligomeric state determines
its function. The CtBP monomer is a co-activator whereas the di-
mer acts as a co-repressor (Bhambhani et al., 2011). How Brakeless
Fig. 5. Brakeless interacts with Med19. (A) A yeast-two hybrid screen used the evolutionarily most conserved part of Brakeless (depicted as darker gray) and the zinc-ﬁnger
unique to the Brakeless-B isoform (white) as a bait. Med19 was identiﬁed from a Drosophila embryo cDNA library. The schematic drawing shows the evolutionarily conserved
part of Med19 in darker gray. Med19 amino acids 66-202 correspond to the selected interaction domain that binds to the Brakeless bait. (B) GST-pulldown assay where GST
and GST-Bks (834-1151) were puriﬁed from E. coli and incubated with full-length in vitro translated 35S-labeled Med19. (C, F, G) Quantitative RT-PCR of gene expression levels
in 2–4 h old Brakeless or Med19 single knockdown and in Brakeless Med19 double knock-down embryos. Columns depict average expression levels relative to a mean of two
reference genes (β-tubulin and RpL32) in embryos derived from females expressing hairpins in the germline under control of an α-tubulin Gal4-VP16 driver. Embryos from
females with only the Gal4 driver (tub) were used as controls. Values in the control (tub) were set to 1. S.D. (n¼3 and 4) is shown, and * indicates Po0.05, two-tailed
unpaired Student's t-test. (C) Expression of brakeless and Med19 in knockdown embryos. (D) Western blot after Brakeless immunoprecipitation in extracts from control (tub)
or Brakeless knock-down embryos. The lanes are spliced together from the same membrane. The input material was loaded on a separate gel and probed with Tubulin
antibody. Quantiﬁcation of Brakeless bands in relation to Tubulin in the input demonstrated a decrease to 84% BksB and 56% BksA in bks RNAi embryos. (E) Brakeless ChIP-
qPCR (anti Bks) and no antibody control at the bks locus. Values were normalized against an intergenic locus devoid of known factors (IG2c). (F) Brakeless-repressed genes
are up-regulated in Med19 knock-down embryos, but expression normalized in double knock-down embryos. (G) Brakeless-activated genes are down-regulated in Med19-
depleted embryos, and expression further reduced in double knock-down embryos, indicating that Brakeless and Med19 collaborate in activating these genes.
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Fig. 6. Schematic model of Brakeless function. (A) Brakeless (Bks) functions as a co-
repressor at the kni, Ctr1A and px genes, interacting with DNA-binding repressors
(R1). These genes are also repressed by Med19, which may interact with different
repressors (R2). Brakeless and Med19 together may in addition be needed for ex-
pression of activators (A) of these genes, so that in double knock-down embryos,
transcription is restored to wild-type levels. (B and C) At other genes, such as sro,
Socs36E, CG30428, and hiw, Brakeless functions as a co-activator by associating with
DNA-binding activators (A). In some cases, a direct interaction with Med19 could be
responsible for Brakeless-mediated activation, whereas Brakeless and Med19 may
associate with different activators at some genes.
F. Crona et al. / Developmental Biology 407 (2015) 173–181180can function as a co-activator at some genes, but as a co-repressor
on others will be an important future question.
Although Brakeless is believed to associate with transcription
factors as a way of recruitment to cis-regulatory DNA, the inter-
actions that result in gene repression or activation are not known.
We therefore performed a yeast two-hybrid screen with the most
evolutionarily conserved part of Brakeless (Fig. S2). Med19, which
is a subunit of the Mediator complex, was identiﬁed as one of the
interacting proteins. The part of Med19 that interacts with
Brakeless is also evolutionarily conserved (Fig. S3). The Mediator
complex is present in all eukaryotes and pivotal for transcription
by RNA polymerase II (reviewed in Kornberg (2005)). By inter-
acting both with enhancer-bound transcription factors and with
the C-terminal domain (CTD) in the largest subunit of RNA poly-
merase II, it functions as a co-regulator that recruits RNA poly-
merase II to the promoter (reviewed in Malik and Roeder (2010)).
Mediator can also stimulate CTD phosphorylation and enhance
transcriptional elongation (reviewed in Carlsten et al. (2013)). In-
terestingly, the Med19 subunit has been identiﬁed in multiple
genetic screens in yeast (Brown et al., 1995; Dettmann et al., 2010;
Friesen et al., 1998; Kremer et al., 2012; Rosenblum-Vos et al.,
1991; Song et al., 1996; Tabtiang and Herskowitz, 1998), suggesting
that this subunit has a crucial function in transmitting transcrip-
tion factor activity to RNA polymerase II. Importantly, in cells
lacking Med19, the Mediator complex can remain intact (Baidoo-
bonso et al., 2007). In contrast to subunits whose absence leads to
Mediator complex disassembly, Med19-depleted cells are there-
fore not expected to cause global gene expression changes, but
rather cause speciﬁc transcriptional defects.
Med19 is implicated both in gene repression and in gene acti-
vation in yeast (Brown et al., 1995; Dettmann et al., 2010; Friesen
et al., 1998; Kremer et al., 2012; Rosenblum-Vos et al., 1991; Song
et al., 1996; Tabtiang and Herskowitz, 1998). In Drosophila, Med19
is required for gene activation by Hox transcription factors, but not
for Hox-mediated repression (Boube et al., 2014). We found that
Brakeless-activated, but not Brakeless-repressed genes, are af-
fected by Med19 and Brakeless double knock-down (Fig. 5). Thisindicates that the interaction of Brakeless with Med19 may be
important for Brakeless-mediated activation, but less so for
Brakeless repressor function (Fig. 6). Consistent with this idea, the
ability of Brakeless to repress a reporter gene in S2 cells when
artiﬁcially tethered to DNA was not affected by Med19 knock-
down (Fig. S4). Taken together, our data suggests that Brakeless
activates transcription by interacting with Med19.
Predicted proteins with sequence similarity to Brakeless can be
found not only in insects, but also in other Ecdysozoa, in Deuter-
ostomes, in Cnidaria, and even in sponges (Fig. S2). However, we
have not found homologous sequences in unicellular eukaryotes,
indicating that Brakeless may have participated in evolution of the
complex gene regulatory networks required for multicellularity. In
this regard, it is interesting that the Brakeless homolog ZNF609 is
part of a protein network for pluripotency in mouse embryonic
stem cells (van den Berg et al., 2010). Learning more about
Brakeless function could provide novel insights into metazoan
gene regulation.Acknowledgments
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